NYSE - Delayed Quote • USD
AptarGroup, Inc. (ATR)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 1.15 | 1.36 | 5.18 | 5.7 |
Low Estimate | 1.11 | 1.31 | 5.04 | 5.54 |
High Estimate | 1.18 | 1.4 | 5.25 | 5.88 |
Year Ago EPS | 0.95 | 1.23 | 4.78 | 5.18 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 6 | 6 |
Avg. Estimate | 890.33M | 931.52M | 3.63B | 3.8B |
Low Estimate | 878.6M | 920.5M | 3.54B | 3.64B |
High Estimate | 906.1M | 937.9M | 3.7B | 3.92B |
Year Ago Sales | 860.07M | 898.79M | 3.49B | 3.63B |
Sales Growth (year/est) | 3.50% | 3.60% | 4.10% | 4.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.9 | 1.14 | 1.27 | 1.12 |
EPS Actual | 0.95 | 1.23 | 1.39 | 1.21 |
Difference | 0.05 | 0.09 | 0.12 | 0.09 |
Surprise % | 5.60% | 7.90% | 9.40% | 8.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1.15 | 1.36 | 5.18 | 5.7 |
7 Days Ago | 1.15 | 1.36 | 5.19 | 5.71 |
30 Days Ago | 1.15 | 1.36 | 5.19 | 5.71 |
60 Days Ago | 1.15 | 1.36 | 5.19 | 5.71 |
90 Days Ago | 1.12 | 1.33 | 5.13 | 5.7 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
CURRENCY IN USD | ATR | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 21.10% | -- | -- | 2.60% |
Next Qtr. | 10.60% | -- | -- | 13.40% |
Current Year | 8.40% | -- | -- | 5.20% |
Next Year | 10.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | 7.00% | -- | -- | 11.11% |
Past 5 Years (per annum) | 3.82% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Wells Fargo: Overweight to Overweight | 3/7/2024 |
Upgrade | Baird: Neutral to Outperform | 1/3/2024 |
Maintains | Wells Fargo: Overweight to Overweight | 9/11/2023 |
Maintains | Wells Fargo: Overweight to Overweight | 7/17/2023 |
Maintains | Deutsche Bank: Buy | 5/1/2023 |
Maintains | Wells Fargo: Overweight | 5/1/2023 |
Related Tickers
UTMD Utah Medical Products, Inc.
66.29
-1.30%
ATRI Atrion Corporation
398.97
-5.95%
ICUI ICU Medical, Inc.
94.53
-2.26%
WST West Pharmaceutical Services, Inc.
368.18
-4.55%
MMSI Merit Medical Systems, Inc.
73.38
-0.88%
XRAY DENTSPLY SIRONA Inc.
30.35
-1.84%
ALC Alcon Inc.
78.84
-0.92%
TFX Teleflex Incorporated
206.71
-2.11%
COO The Cooper Companies, Inc.
89.93
-0.30%
STVN Stevanato Group S.p.A.
27.52
+0.77%